Glucoverdazyl-enhanced dynamic contrast enhanced magnetic resonance imaging...
Glucoverdazyl-enhanced dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) of folic acid-induced nephropathy. T1-weighted images of kidneys at t = 2.5 min post-injection (top) and renal decay time constant (RDTC) maps (bottom). The white scalebar represents 2 mm.

Image source: Calvert et al., Nature Communications 2023 (CC BY 4.0)

News • DCE-MRI urography

Metal-free kidney MRI dye for more personalized diagnostics

University of Ottawa scientists have introduced a metal-free MRI dye capable of mapping kidney function with unprecedented accuracy. This technique will modernize urology, allow for more personalized care and — ultimately — improve patient outcomes.

One in 10 Canadians suffer from some form of kidney disease. Current clinical methods for diagnosis rely on entering demographic and blood-based measurements into an equation to obtain an average value of kidney function for each patient. But this equation has a large error margin (around 20%) and doesn’t pinpoint which kidney is diseased or where the problem lies. 

By proposing a new dye that addresses the safety limitations associated with traditional MRI contrast agents, this study opens the door to personalized diagnosis and treatment of kidney diseases. The dye can help obtain spatial data and quantitative glomerular filtration rate measurements for both kidneys, surpassing the limitations of current clinical methods. 

The study was published in Nature Communications

portrait of adam shuhendler
Adam J. Shuhendler, Associate professor in the Department of Chemistry and Biomolecular Sciences of uOttawa

Image source: University of Ottawa

“In speaking with radiologists and nephrologists, it became clear that we needed to do better. Magnetic resonance imaging (MRI) provides excellent anatomical images but lacks suitable contrast agents for reporting kidney function,” says Adam J. Shuhendler, associate professor in the Department of Chemistry and Biomolecular Sciences of the University of Ottawa’s Faculty of Science. “Existing MRI dyes with heavy metal atoms can be toxic if kidney function is impaired. This study addresses this limitation by introducing a metal-free MRI dye that enables safe and effective mapping of kidney function, providing crucial information for personalized diagnosis and treatment planning.” 

The Canadian Institutes of Health Research-funded study, led by Nicholas D. Calvert, a PhD student in chemistry and biomolecular sciences in Shuhendler’s lab, was conducted with the help of Alexia Kirby, Mojmír Suchý, Peter Pallister, Aidan A. Torrens, Dylan Burger, Gerd Melkus and Nicola Schieda, from the Molecular Medicine Lab at the University of Ottawa and the preclinical MRI facility at the University of Ottawa Heart Institute.

Unlike the current equation-based method and traditional gadolinium-based MRI contrast agents, the novel dye enabled precise characterization of kidney function, even when one kidney was dysfunctional

Adam J. Shuhendler

The research team discovered a promising scaffold called verdazyl, which served as the basis for the metal-free MRI dye. After optimizing its synthesis, the dye was injected into healthy mice and imaged using MRI. The results demonstrated the efficacy and safety of the verdazyl dye, showing localization in the kidneys. Mouse models of kidney disease were subsequently used to validate the imaging-based method for mapping glomerular filtration rate (GFR). The results were compared with histology and established methods for determining GFR in mice, further confirming the reliability of the MRI-based approach. 

“Unlike the current equation-based method and traditional gadolinium-based MRI contrast agents, the novel dye enabled precise characterization of kidney function, even when one kidney was dysfunctional,” says Shuhendler. “Remarkably, the study also revealed compensatory responses of healthy kidneys to their diseased counterparts.” 

The introduction of the metal-free MRI dye represents a significant breakthrough in personalized urology. Using an accurate spatial map of kidney function, clinicians can develop tailored diagnosis and treatment plans for patients with kidney disease. The dye also presents as a chemical platform, which Shuhendler and his team are currently exploiting to target other organs and disease for MRI-based functional assessment. “With our new metal-free MRI dye, we have squarely entered the era of personalized medicine for kidney disease,” concludes Shuhendler. 


Source: University of Ottawa

14.07.2023

Read all latest stories

Related articles

Photo

News • Production of biological contrast agents

Hyperpolarized MRI to advance cancer imaging

A new imaging method devised by German researchers offers a fast and cost-effective way to observe abnormal metabolic processes live in the MRI scanner.

Photo

Article • Plenary discussion at ECR 2023

Sustainable radiology: why it takes more than “greener” imaging systems

It’s clear that radiology is lacking in the “green” department: healthcare still causes a large share of global greenhouse gas (GHG) emissions, not least due to diagnostic imaging. Dr Sarah…

Photo

News • Philips joins European Federation for Cancer Images (EUCAIM)

Advancing precision medicine for Europe’s cancer patients

Philips is an active participant in the new European Federation for Cancer Images consortium (EUCAIM) – a project launched in the run-up to World Cancer Day 2023.

Related products

Subscribe to Newsletter